Drugs merger seeks strength in breadth

Ehsan Masood

Nature, 1998, vol. 391, issue 6668, 621-621

Abstract: london A single pharmaceutical company combining expertise in chemistry, biology, and genomics will emerge if Glaxo Wellcome and SmithKline Beecham decide to merge.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35449 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:391:y:1998:i:6668:d:10.1038_35449

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35449

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().